Fangmeng Y. Fu

Chinese Academy Of Medical Sciences And Peking Union Medical College
Shenzhen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 90 publications

Reply to "Design-analysis mismatch in the analysis of longitudinal HER2 data in breast cancer".

Reply to "Design-analysis mismatch in the analysis of longitudinal HER2 data in breast cancer".

Journal: Cancer

Published: March 30, 2026

Local Consolidative Radiotherapy Combined With Immunochemotherapy for De Novo Metastatic Nasopharyngeal Carcinoma: A Meta-Analysis.

Local Consolidative Radiotherapy Combined With Immunochemotherapy for De Novo Metastatic Nasopharyngeal Carcinoma: A Meta-Analysis.

Journal: Head & neck

Published: February 18, 2026

Efficacy and safety of hypofractionated radiotherapy combined with temozolomide in patients with newly diagnosed glioblastoma with poor prognosis: a single-center retrospective analysis.

Efficacy and safety of hypofractionated radiotherapy combined with temozolomide in patients with newly diagnosed glioblastoma with poor prognosis: a single-center retrospective analysis.

Journal: Frontiers in oncology

Published: January 06, 2026

Immunotherapy plus induction chemotherapy followed by radiotherapy alone or one cycle of concurrent chemotherapy with cisplatin vs induction chemotherapy followed by two cycles of concurrent chemotherapy with cisplatin in locoregionally advanced nasopharyngeal carcinoma.

Immunotherapy plus induction chemotherapy followed by radiotherapy alone or one cycle of concurrent chemotherapy with cisplatin vs induction chemotherapy followed by two cycles of concurrent chemotherapy with cisplatin in locoregionally advanced nasopharyngeal carcinoma.

Journal: Frontiers in immunology

Published: December 13, 2025

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

Journal: The Lancet. Oncology

Published: November 14, 2025

Development and validation of an interpretable machine learning model integrating inflammatory blood biomarkers for predicting postoperative breast cancer-related lymphedema: A prospective cohort study.

Development and validation of an interpretable machine learning model integrating inflammatory blood biomarkers for predicting postoperative breast cancer-related lymphedema: A prospective cohort study.

Journal: Surgery

Published: November 14, 2025

The evolution and prognostic impact of HER2-low, HER2-ultralow, and HER2-null status in HER2-negative early breast cancer: A pre- to post-neoadjuvant chemotherapy study.

The evolution and prognostic impact of HER2-low, HER2-ultralow, and HER2-null status in HER2-negative early breast cancer: A pre- to post-neoadjuvant chemotherapy study.

Journal: Cancer

Published: October 17, 2025

Perineural invasion and risk of lymph node metastasis in early-stage operable breast cancer: a large-scale propensity-matched cohort study and meta-analysis.

Perineural invasion and risk of lymph node metastasis in early-stage operable breast cancer: a large-scale propensity-matched cohort study and meta-analysis.

Journal: Therapeutic advances in medical oncology

Published: September 20, 2025

Toripalimab plus gemcitabine and cisplatin induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective study.

Toripalimab plus gemcitabine and cisplatin induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective study.

Journal: Frontiers in oncology

Published: September 13, 2025

Impact of COVID-19 on neoadjuvant chemotherapy efficacy in patients with breast cancer: An ambidirectional cohort study and mendelian randomization analysis.

Impact of COVID-19 on neoadjuvant chemotherapy efficacy in patients with breast cancer: An ambidirectional cohort study and mendelian randomization analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 04, 2025

Feasibility and accuracy of targeted axillary dissection by carbon tattooing in biopsy-proven node-positive breast cancer: A prospective study.

Feasibility and accuracy of targeted axillary dissection by carbon tattooing in biopsy-proven node-positive breast cancer: A prospective study.

Journal: Cancer

Published: March 27, 2025

Prognostic value of nuclear features based on tumor-associated collagen signatures in breast cancer.

Prognostic value of nuclear features based on tumor-associated collagen signatures in breast cancer.

Journal: NPJ breast cancer

Published: March 25, 2025

Showing 1-12 of 90

Last Updated: 09/26/2026